BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gharbia S, Balta C, Herman H, Rosu M, Váradi J, Bácskay I, Vecsernyés M, Gyöngyösi S, Fenyvesi F, Voicu SN, Stan MS, Cristian RE, Dinischiotu A, Hermenean A. Enhancement of Silymarin Anti-fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver Fibrosis. Front Pharmacol 2018;9:883. [PMID: 30150935 DOI: 10.3389/fphar.2018.00883] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Carvalho LCF, Ferreira FM, Dias BV, Azevedo DCD, de Souza GHB, Milagre MM, de Lana M, Vieira PMDA, Carneiro CM, Paula-gomes SD, Cangussu SD, Costa DC. Silymarin inhibits the lipogenic pathway and reduces worsening of non-alcoholic fatty liver disease (NAFLD) in mice. Archives of Physiology and Biochemistry 2022. [DOI: 10.1080/13813455.2022.2138445] [Reference Citation Analysis]
2 Gharbia S, Nazarie S, Dinescu S, Balta C, Herman H, Peteu VE, Gherghiceanu M, Hermenean A, Costache M. Adipose-Derived Stem Cells (ADSCs) Supplemented with Hepatocyte Growth Factor (HGF) Attenuate Hepatic Stellate Cell Activation and Liver Fibrosis by Inhibiting the TGF-β/Smad Signaling Pathway in Chemical-Induced Liver Fibrosis Associated with Diabetes. Cells 2022;11:3338. [DOI: 10.3390/cells11213338] [Reference Citation Analysis]
3 Resende VQ, Reis-goes KH, Finato AC, de Fátima Almeida-donanzam D, dos Santos AR, Perico J, Amorim BC, Venturini J. Combined Silymarin and Cotrimoxazole Therapy Attenuates Pulmonary Fibrosis in Experimental Paracoccidioidomycosis. JoF 2022;8:1010. [DOI: 10.3390/jof8101010] [Reference Citation Analysis]
4 Dykman LA, Staroverov SA, Fomin AS, Gabalov KP. Obtaining antibodies to silymarin using the adjuvant properties of gold nanoparticles and their application to study the uptake of silymarin into cells. Computational Biophysics and Nanobiophotonics 2022. [DOI: 10.1117/12.2625711] [Reference Citation Analysis]
5 Khalil HE, Ibrahim HM, El-fass KA, Akrawi SH, Morsy MA. Orientin Alleviates Liver Inflammation via Downregulation of ZEB-2/PTEN Markers—Hepatic Stellate Cells Approach. Applied Sciences 2022;12:2725. [DOI: 10.3390/app12052725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Paltinean G, Babes-Bolyai University, Faculty of Chemistry and Chemical Engineering, Research Centre of Physical Chemistry, Tomoaia G, Riga S, Mocanu A, Tomoaia-cotisel M, Iuliu Hatieganu University of Medicine and Pharmacy, Department of Orthopedic Surgery, Academy of Romanian Scientist, Babes-Bolyai University, Faculty of Chemistry and Chemical Engineering, Research Centre of Physical Chemistry, Academy of Romanian Scientist, Babes-Bolyai University, Faculty of Chemistry and Chemical Engineering, Research Centre of Physical Chemistry, Babes-Bolyai University, Faculty of Chemistry and Chemical Engineering, Research Centre of Physical Chemistry, Academy of Romanian Scientist. Silymarin Based Complexes – a mini review. AnnalsARSciBio 2022;11:146-166. [DOI: 10.56082/annalsarscibio.2022.1.146] [Reference Citation Analysis]
7 Jiao W, Bai M, Yin H, Liu J, Sun J, Su X, Zeng H, Wen J. Therapeutic Effects of an Inhibitor of Thioredoxin Reductase on Liver Fibrosis by Inhibiting the Transforming Growth Factor-β1/Smads Pathway. Front Mol Biosci 2021;8:690170. [PMID: 34540892 DOI: 10.3389/fmolb.2021.690170] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Poltavets YI, Kuznetsov SL, Tubasheva IA, Murav’eva AI, Gukasova NV. Nano- and Microsized Forms of Silymarin and Silybin. Nanotechnol Russia 2021;16:115-37. [DOI: 10.1134/s2635167621020105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Du JJ, Sun JC, Li N, Li XQ, Sun WY, Wei W. β-Arrestin2 deficiency attenuates oxidative stress in mouse hepatic fibrosis through modulation of NOX4. Acta Pharmacol Sin 2021;42:1090-100. [PMID: 33116250 DOI: 10.1038/s41401-020-00545-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
10 Xu L, Huang Q, Tan X, Zhao Q, Wu J, Liao H, Ai W, Liu Y, Lai Z, Fu L. Patchouli alcohol ameliorates acute liver injury via inhibiting oxidative stress and gut-origin LPS leakage in rats. Int Immunopharmacol 2021;98:107897. [PMID: 34182243 DOI: 10.1016/j.intimp.2021.107897] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Ho CH, Huang JH, Sun MS, Tzeng IS, Hsu YC, Kuo CY. Wild Bitter Melon Extract Regulates LPS-Induced Hepatic Stellate Cell Activation, Inflammation, Endoplasmic Reticulum Stress, and Ferroptosis. Evid Based Complement Alternat Med 2021;2021:6671129. [PMID: 34239589 DOI: 10.1155/2021/6671129] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
12 Ciceu A, Balta C, Herman H, Gharbia S, Ignat SR, Dinescu S, Váradi J, Fenyvesi F, Gyöngyösi S, Hermenean A, Costache M. Complexation with Random Methyl-β-Cyclodextrin and (2-Hidroxypropyl)-β-Cyclodextrin Enhances In Vivo Anti-Fibrotic and Anti-Inflammatory Effects of Chrysin via the Inhibition of NF-κB and TGF-β1/Smad Signaling Pathways and Modulation of Hepatic Pro/Anti-Fibrotic miRNA. Int J Mol Sci 2021;22:1869. [PMID: 33668543 DOI: 10.3390/ijms22041869] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
13 Ignat SR, Dinescu S, Váradi J, Fenyvesi F, Nguyen TLP, Ciceu A, Hermenean A, Costache M. Complexation with Random Methyl-β-Cyclodextrin and (2-Hydroxypropyl)-β-Cyclodextrin Promotes Chrysin Effect and Potential for Liver Fibrosis Therapy. Materials (Basel) 2020;13:E5003. [PMID: 33171970 DOI: 10.3390/ma13215003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhang T, Hao H, Zhou Z, Zeng T, Zhang J, Zhou X. Lipoxin A4 inhibited the activation of hepatic stellate cells -T6 cells by modulating profibrotic cytokines and NF-κB signaling pathway. Prostaglandins & Other Lipid Mediators 2020;146:106380. [DOI: 10.1016/j.prostaglandins.2019.106380] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
15 Li L, Yang C, Yang J, Li H, Zhang B, Zhou H, Hu S, Wang K, Huang C, Meng X, Zhou H, Zhang L, Li J, Xu T. ZEB1 regulates the activation of hepatic stellate cells through Wnt/β-catenin signaling pathway. European Journal of Pharmacology 2019;865:172787. [DOI: 10.1016/j.ejphar.2019.172787] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
16 Di Costanzo A, Angelico R. Formulation Strategies for Enhancing the Bioavailability of Silymarin: The State of the Art. Molecules 2019;24:E2155. [PMID: 31181687 DOI: 10.3390/molecules24112155] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 20.3] [Reference Citation Analysis]